Axon Enterprise, Inc. (NASDAQ:AXON) is a leading provider of public safety technology, known for its development of TASER devices and body cameras. The company is set to release its fourth-quarter 2024 earnings on February 25, 2025. Analysts are closely watching the earnings per share (EPS) and revenue figures, which are key indicators of the company's financial health.
Wall Street analysts estimate Axon's EPS to be $1.37, while the Zacks Consensus Estimate is slightly higher at $1.51. This represents a significant 34.8% increase from the previous year, highlighting the company's strong performance. Revenue projections also show growth, with estimates around $566.7 million to $567.6 million, marking a 31.3% year-over-year increase.
For the entire year of 2024, Axon's revenue is projected to reach $2.08 billion, a 32.8% increase from the previous year. The consensus estimate for annual EPS is $5.29, reflecting a 27.8% rise. Axon's consistent track record of exceeding earnings expectations may influence investor decisions, as highlighted by Zacks.
Axon's valuation metrics indicate a high level of investor confidence. The company's P/E ratio is approximately 130.23, suggesting investors are willing to pay over 130 times its earnings. The price-to-sales ratio is about 20.16, and the enterprise value to sales ratio is similar at 20.17, reflecting the company's strong market position.
The company's financial stability is further supported by a debt-to-equity ratio of 0.34, indicating low debt levels. Axon's current ratio of about 2.96 shows strong liquidity, ensuring it can cover short-term liabilities. These factors contribute to the company's robust financial health and investor appeal.
